U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900438) titled 'A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China' on Oct. 21.
Brief Summary: The purpose of this clinical study is to find out what happens to kidney and heart health during treatment with a medicine called semaglutide, which is given as an injection under the skin. The clinical study will also look at whether this medicine is safe for adults who have type 2 diabetes (T2D) and chronic kidney disease (CKD). This study will last for about 60 to 172 weeks.
Study Start Date: Oct. 12
Study Type: INTERVENTIONAL
Condition:
Cardiovascular Risk...